CTX vs. META, DB, LABS, NRTH, MRV, CWEB, MPH, FLWR, KHRN, and AH
Should you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Meta Growth (META), Decibel Cannabis (DB), MediPharm Labs (LABS), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), Charlotte's Web (CWEB), Medicure (MPH), Flowr (FLWR), Khiron Life Sciences (KHRN), and Aleafia Health (AH). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Crescita Therapeutics vs. Its Competitors
Crescita Therapeutics (TSE:CTX) and Meta Growth (CVE:META) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.
Crescita Therapeutics has higher earnings, but lower revenue than Meta Growth. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.
Meta Growth has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -15.73%. Meta Growth's return on equity of 0.00% beat Crescita Therapeutics' return on equity.
In the previous week, Meta Growth had 4 more articles in the media than Crescita Therapeutics. MarketBeat recorded 4 mentions for Meta Growth and 0 mentions for Crescita Therapeutics. Meta Growth's average media sentiment score of 0.22 beat Crescita Therapeutics' score of 0.00 indicating that Meta Growth is being referred to more favorably in the news media.
Summary
Meta Growth beats Crescita Therapeutics on 8 of the 10 factors compared between the two stocks.
Get Crescita Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Crescita Therapeutics Competitors List
Related Companies and Tools
This page (TSE:CTX) was last updated on 7/7/2025 by MarketBeat.com Staff